Article
AAVs Targeting Human Carbonic Anhydrase IV Enhance Gene Delivery to the Brain
2025-04-22
Abstract excerpt
<h4>Summary</h4> Clinically approved gene therapies based on natural adeno-associated virus (AAV) serotypes have restricted applications, particularly in the brain, due to their poor targeting, high dose requirements, and resulting safety concerns. Directed evolution of enhanced AAV capsids in mice or non-human primates (NHPs) has resulted in markedly improved performance in those species, but inter-species diffe...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b691eb40-099d-5f0f-9200-425f08e2a7c7
- DOI
- 10.1101/2025.04.21.649868
